<DOC>
	<DOCNO>NCT00064272</DOCNO>
	<brief_summary>RATIONALE : The herb ginger may help reduce prevent nausea vomit patient receive chemotherapy cancer . PURPOSE : This randomized phase II trial study well ginger work reduce prevent nausea vomit patient receive chemotherapy cancer .</brief_summary>
	<brief_title>UMCCOP 02-01 Ginger Treating Nausea Vomiting Patients Receiving Chemotherapy Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare prevalence severity delay nausea vomit patient cancer undergo chemotherapy treat lower-dose ginger v higher-dose ginger v placebo . Secondary - Compare prevalence severity acute nausea vomit patient treat regimen . - Compare safety regimens patient . - Determine whether patient determine receive placebo study drug , variable ( e.g. , taste , smell , decrease nausea vomit ) . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients randomize 1 3 treatment arm . Patients stratify accord concurrent antiemetic type ( 5-HT_3 antagonist v NK1 antagonist ) . - Arm I : Patients receive lower-dose oral ginger twice daily . - Arm II : Patients receive higher-dose oral ginger twice daily . - Arm III : Patients receive oral placebo twice daily . In arm , treatment begin immediately chemotherapy treatment continue 3 day . Patients follow 1 week . PROJECTED ACCRUAL : A total 180 patient ( 60 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm diagnosis cancer Currently receive chemotherapy* contain chemotherapeutic agent dose experience nausea and/or vomit severity ( delay acute ) Chemotherapy regimens may give orally , IV , continuous infusion ( single day regimen ) Must receive least 1 prior chemotherapy* course contain chemotherapeutic agent meet follow criterion : Agent schedule next round chemotherapy Experienced nausea and/or vomit severity ( delay acute ) Must plan receive concurrent 5HT_3 receptor antagonist antiemetic ( e.g. , ondansetron , granisetron , dolasetron mesylate , palanosetron ) antiemetic aprepritant ( e.g. , Emend® ) chemotherapy No symptomatic brain metastasis NOTE : *Chemotherapy may adjuvant , neoadjuvant , curative , palliative PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy Not specify Hematopoietic No history bleed disorder No thrombocytopenia Hepatic Not specify Renal Not specify Gastrointestinal Able swallow capsule No gastric ulcer No clinical evidence current impend bowel obstruction Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Able understand English Able complete study questionnaires No allergy ginger PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics No prior chemotherapy regimen multiple day dose Endocrine therapy Not specify Radiotherapy No concurrent radiotherapy classify high intermediate risk cause vomit , include radiotherapy follow area : Total body irradiation Hemibody Upper abdomen Abdominalpelvic mantle Cranium ( radiosurgery ) Craniospinal radiotherapy Surgery Not specify Other More 1 week since prior ginger ( teas , capsule , tincture ) No concurrent ginger ( teas , capsule , tincture ) Concurrent food make small amount ( ¼ teaspoon ) ginger ( powder fresh ) allow No concurrent therapeuticdoses warfarin , aspirin , heparin Concurrent lowdose warfarin maintain peripheral central venous access , lowdose aspirin ( ≤ 81 mg ) , lowdose heparin allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>nausea vomit</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>